1. Home
  2. CVKD vs ECDA Comparison

CVKD vs ECDA Comparison

Compare CVKD & ECDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • ECDA
  • Stock Information
  • Founded
  • CVKD 2022
  • ECDA 2013
  • Country
  • CVKD United States
  • ECDA United States
  • Employees
  • CVKD N/A
  • ECDA N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • ECDA Auto Manufacturing
  • Sector
  • CVKD Health Care
  • ECDA Consumer Discretionary
  • Exchange
  • CVKD Nasdaq
  • ECDA Nasdaq
  • Market Cap
  • CVKD 34.2M
  • ECDA 34.8M
  • IPO Year
  • CVKD 2023
  • ECDA N/A
  • Fundamental
  • Price
  • CVKD $17.77
  • ECDA $0.75
  • Analyst Decision
  • CVKD Strong Buy
  • ECDA
  • Analyst Count
  • CVKD 1
  • ECDA 0
  • Target Price
  • CVKD $32.00
  • ECDA N/A
  • AVG Volume (30 Days)
  • CVKD 44.3K
  • ECDA 26.0K
  • Earning Date
  • CVKD 05-08-2025
  • ECDA 03-18-2025
  • Dividend Yield
  • CVKD N/A
  • ECDA N/A
  • EPS Growth
  • CVKD N/A
  • ECDA N/A
  • EPS
  • CVKD N/A
  • ECDA N/A
  • Revenue
  • CVKD N/A
  • ECDA $25,728,409.00
  • Revenue This Year
  • CVKD N/A
  • ECDA $122.74
  • Revenue Next Year
  • CVKD N/A
  • ECDA $26.95
  • P/E Ratio
  • CVKD N/A
  • ECDA N/A
  • Revenue Growth
  • CVKD N/A
  • ECDA 123.27
  • 52 Week Low
  • CVKD $5.40
  • ECDA $0.57
  • 52 Week High
  • CVKD $22.90
  • ECDA $1.55
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 49.27
  • ECDA 39.79
  • Support Level
  • CVKD $14.64
  • ECDA $0.57
  • Resistance Level
  • CVKD $17.58
  • ECDA $0.75
  • Average True Range (ATR)
  • CVKD 1.86
  • ECDA 0.11
  • MACD
  • CVKD -0.29
  • ECDA -0.01
  • Stochastic Oscillator
  • CVKD 39.10
  • ECDA 40.59

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About ECDA ECD Automotive Design Inc.

ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the most customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.

Share on Social Networks: